446 related articles for article (PubMed ID: 17360873)
1. Tafenoquine for the treatment of recurrent Plasmodium vivax malaria.
Kitchener S; Nasveld P; Edstein MD
Am J Trop Med Hyg; 2007 Mar; 76(3):494-6. PubMed ID: 17360873
[TBL] [Abstract][Full Text] [Related]
2. Randomized trial of 3-dose regimens of tafenoquine (WR238605) versus low-dose primaquine for preventing Plasmodium vivax malaria relapse.
Walsh DS; Wilairatana P; Tang DB; Heppner DG; Brewer TG; Krudsood S; Silachamroon U; Phumratanaprapin W; Siriyanonda D; Looareesuwan S
Clin Infect Dis; 2004 Oct; 39(8):1095-103. PubMed ID: 15486831
[TBL] [Abstract][Full Text] [Related]
3. Randomized dose-ranging study of the safety and efficacy of WR 238605 (Tafenoquine) in the prevention of relapse of Plasmodium vivax malaria in Thailand.
Walsh DS; Looareesuwan S; Wilairatana P; Heppner DG; Tang DB; Brewer TG; Chokejindachai W; Viriyavejakul P; Kyle DE; Milhous WK; Schuster BG; Horton J; Braitman DJ; Brueckner RP
J Infect Dis; 1999 Oct; 180(4):1282-7. PubMed ID: 10479159
[TBL] [Abstract][Full Text] [Related]
4. Tafenoquine plus chloroquine for the treatment and relapse prevention of Plasmodium vivax malaria (DETECTIVE): a multicentre, double-blind, randomised, phase 2b dose-selection study.
Llanos-Cuentas A; Lacerda MV; Rueangweerayut R; Krudsood S; Gupta SK; Kochar SK; Arthur P; Chuenchom N; Möhrle JJ; Duparc S; Ugwuegbulam C; Kleim JP; Carter N; Green JA; Kellam L
Lancet; 2014 Mar; 383(9922):1049-58. PubMed ID: 24360369
[TBL] [Abstract][Full Text] [Related]
5. Studies on Plasmodium vivax relapse pattern in Kheda district, Gujarat.
Srivastava HC; Sharma SK; Bhatt RM; Sharma VP
Indian J Malariol; 1996 Dec; 33(4):173-9. PubMed ID: 9125831
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of monthly tafenoquine for prophylaxis of Plasmodium vivax and multidrug-resistant P. falciparum malaria.
Walsh DS; Eamsila C; Sasiprapha T; Sangkharomya S; Khaewsathien P; Supakalin P; Tang DB; Jarasrumgsichol P; Cherdchu C; Edstein MD; Rieckmann KH; Brewer TG
J Infect Dis; 2004 Oct; 190(8):1456-63. PubMed ID: 15378438
[TBL] [Abstract][Full Text] [Related]
7. Treatment of acute vivax malaria with tafenoquine.
Nasveld P; Kitchener S
Trans R Soc Trop Med Hyg; 2005 Jan; 99(1):2-5. PubMed ID: 15550254
[TBL] [Abstract][Full Text] [Related]
8. Chloroquine sensitivity of Plasmodium vivax in Thailand.
Looareesuwan S; Wilairatana P; Krudsood S; Treeprasertsuk S; Singhasivanon P; Bussaratid V; Chokjindachai W; Viriyavejakul P; Chalermrut K; Walsh D S; White J
Ann Trop Med Parasitol; 1999 Apr; 93(3):225-30. PubMed ID: 10562823
[TBL] [Abstract][Full Text] [Related]
9. Operational effectiveness of tafenoquine and primaquine for the prevention of Plasmodium vivax recurrence in Brazil: a retrospective observational study.
Brito M; Rufatto R; Brito-Sousa JD; Murta F; Sampaio V; Balieiro P; Baía-Silva D; Castro V; Alves B; Alencar A; Duparc S; Grewal Daumerie P; Borghini-Fuhrer I; Jambert E; Peterka C; Edilson Lima F; Carvalho Maia L; Lucena Cruz C; Maciele B; Vasconcelos M; Machado M; Augusto Figueira E; Alcirley Balieiro A; Batista Pereira D; Lacerda M
Lancet Infect Dis; 2024 Jun; 24(6):629-638. PubMed ID: 38452779
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of three chloroquine-primaquine regimens for treatment of Plasmodium vivax malaria in Colombia.
Alvarez G; Piñeros JG; Tobón A; Ríos A; Maestre A; Blair S; Carmona-Fonseca J
Am J Trop Med Hyg; 2006 Oct; 75(4):605-9. PubMed ID: 17038680
[TBL] [Abstract][Full Text] [Related]
11. Optimal balance of benefit versus risk for tafenoquine in the treatment of Plasmodium vivax malaria.
Sharma R; Sharma H; Jones S; Borghini-Fuhrer I; Domingo GJ; Gibson RA; Rolfe K; Tan L; Fiţa IG; Chen C; Bird P; Pingle A; Duparc S
Malar J; 2024 May; 23(1):145. PubMed ID: 38741094
[TBL] [Abstract][Full Text] [Related]
12. Assessment of therapeutic efficacy of chloroquine for vivax malaria in Thailand.
Vijaykadga S; Rojanawatsirivej C; Congpoung K; Wilairatana P; Satimai W; Uaekowitchai C; Pumborplub B; Sittimongkol S; Pinyorattanachote A; Prigchoo P
Southeast Asian J Trop Med Public Health; 2004 Sep; 35(3):566-9. PubMed ID: 15689067
[TBL] [Abstract][Full Text] [Related]
13. [Recurrent Plasmodium vivax malaria in spite of primaquine follow-up treatment].
Telgt DS; Mulder L; Dolmans WM
Ned Tijdschr Geneeskd; 1997 Sep; 141(37):1783-6. PubMed ID: 9545728
[TBL] [Abstract][Full Text] [Related]
14. Radical curative efficacy of five-day regimen of primaquine for treatment of Plasmodium vivax malaria in India.
Yadav RS; Ghosh SK
J Parasitol; 2002 Oct; 88(5):1042-4. PubMed ID: 12435158
[TBL] [Abstract][Full Text] [Related]
15. Malaria prophylaxis/radical cure: recent experiences of the Australian Defence Force.
Edstein MD; Walsh DS; Eamsila C; Sasiprapha T; Nasveld PE; Kitchener S; Rieckmann KH
Med Trop (Mars); 2001; 61(1):56-8. PubMed ID: 11584657
[TBL] [Abstract][Full Text] [Related]
16. Tafenoquine versus Primaquine to Prevent Relapse of Plasmodium vivax Malaria.
Llanos-Cuentas A; Lacerda MVG; Hien TT; Vélez ID; Namaik-Larp C; Chu CS; Villegas MF; Val F; Monteiro WM; Brito MAM; Costa MRF; Chuquiyauri R; Casapía M; Nguyen CH; Aruachan S; Papwijitsil R; Nosten FH; Bancone G; Angus B; Duparc S; Craig G; Rousell VM; Jones SW; Hardaker E; Clover DD; Kendall L; Mohamed K; Koh GCKW; Wilches VM; Breton JJ; Green JA
N Engl J Med; 2019 Jan; 380(3):229-241. PubMed ID: 30650326
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic efficacy of artesunate in Plasmodium vivax malaria in Thailand.
Hamedi Y; Safa O; Zare S; Tan-ariya P; Kojima S; Looareesuwan S
Southeast Asian J Trop Med Public Health; 2004 Sep; 35(3):570-4. PubMed ID: 15689068
[TBL] [Abstract][Full Text] [Related]
18. Estimation of the Antirelapse Efficacy of Tafenoquine, Using Plasmodium vivax Genotyping.
Beck HP; Wampfler R; Carter N; Koh G; Osorio L; Rueangweerayut R; Krudsood S; Lacerda MV; Llanos-Cuentas A; Duparc S; Rubio JP; Green JA
J Infect Dis; 2016 Mar; 213(5):794-9. PubMed ID: 26500351
[TBL] [Abstract][Full Text] [Related]
19. A randomized, double-blind, active-control trial to evaluate the efficacy and safety of a three day course of tafenoquine monotherapy for the treatment of Plasmodium vivax malaria.
Fukuda MM; Krudsood S; Mohamed K; Green JA; Warrasak S; Noedl H; Euswas A; Ittiverakul M; Buathong N; Sriwichai S; Miller RS; Ohrt C
PLoS One; 2017; 12(11):e0187376. PubMed ID: 29121061
[TBL] [Abstract][Full Text] [Related]
20. Tafenoquine for preventing relapse in people with Plasmodium vivax malaria.
Rajapakse S; Rodrigo C; Fernando SD
Cochrane Database Syst Rev; 2015 Apr; 2015(4):CD010458. PubMed ID: 25921416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]